Periodontal Therapeutics Market (Product Type - Systemic Antibiotics (Doxycycline, Minocycline, Metronidazole), Local Antibiotics (Arestin, Atridox, PerioChip); Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Drug Stores, E-commerce - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2030

the global periodontal therapeutics market for the historical period 2017–2018 and forecast period 2019–2027, rise in reported cases of periodontitis, Increase in prevalence of diabetes, rise in global geriatric population and surge in awareness about oral health are projected to drive the global periodontal therapeutics market

According to the report, the global periodontal therapeutics market was valued at US$ 536.8 Mn in 2018 and is anticipated to expand at a CAGR of 8.8% from 2019 to 2030

Rise in Global Burden of Periodontal Diseases: A Key Driver

Periodontal diseases comprising gingivitis and periodontitis are prevalent both in developing and developed countries and affect around 20% to 50% of the global population

According to the Global Burden of Disease Study (GBD, 1990–2010), severe periodontitis is the 6th most prevalent disease worldwide, and has an overall prevalence of 11.2% and an estimated 743 million people worldwide are affected by it. The global burden of periodontal diseases has increased by as much as 57.3% from 1990 to 2010.

Periodontitis is one of the major causes of tooth loss in adult population across the world. These individuals are at risk of edentulism, masticatory dysfunction, and multiple tooth loss which in turn affects nutrition, self-esteem, and quality of life as well as imposes high health care and significant socio-economic costs.

The global cost of lost productivity due to severe periodontitis is estimated to be around US$ 54 Bn per year, while the total economic impact of periodontal diseases accounts for a major component of the US$ 442 Bn direct and indirect cost caused due to oral diseases.

Surge in Awareness About Oral Health to Augment Global Market

Oral health programs work for formulation of national and community policies on effective control of diet and nutrition risk factors for oral diseases such as periodontal disease, dental disease, etc.

Periodontal diseases have a significant socio-economic impact on populations and governments across the world; however, treatment to these diseases still remains unavailable in developing countries due to low priority accorded to these diseases

The Global Periodontal Health Project (GPHP) was launched in October 2015 in order to reduce the overall global burden of periodontal diseases. The project aims to decrease the burden associated with these diseases by raising awareness of its impact and engaging oral health and other health professionals, policymakers, educators, and the general public in promoting periodontal health.

The Global Periodontal Health Project aims to make periodontal health a priority issue at the national level by engaging with Ministers of Health, Chief Dental Officers and the local populations, and also increase the disease awareness levels by actively disseminating dental educational promotional tools.

Uninsured Dental Care in Several Developed and Developing Countries to Hamper Global Periodontal Therapeutics Market

Advanced dental and periodontal procedures turn out to be too expensive for an average citizen in both developed and developing countries

Oral health care coverage is seen to be low in low- and middle-income countries. Dental care is not insured in several developed countries such as Canada and the U.S. In the U.S., only the most rudimentary dental care is covered by health insurance plan. According to the National Association of Dental Plans, over 114 million people in the U.S. were known to be without dental coverage in 2014.

North America to Account for Major Share of Global Periodontal Therapeutics Market

North America is projected to account for leading share of the global periodontal therapeutics market due to rise in product approvals, well-established health care infrastructure, increase in technological advancements, rise in number of well-equipped laboratories, surge in research & developmental activities in periodontal therapeutics, and presence of key players

The periodontal therapeutics market in Asia Pacific is projected to grow at a rapid pace during the forecast period due to increase in geriatric population, rise in research & developmental activities, surge in initiatives by governments in the health care sector, and rise in interest of key players in expanding presence in the region

Global Periodontal Therapeutics Market: Competitive Landscape

This report profiles major players in the global periodontal therapeutics market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments

Key players operating in the global periodontal therapeutics market include

• Den-Mat Holdings, LLC
• Valeant Pharmaceuticals International, Inc.
• Dexcel Pharma
• 3M Company
• Oral Science
• Kaken Pharmaceutical Co., Ltd.

Key Questions Answered in Global Periodontal Therapeutics Market Report

• What is the scope of growth of product companies in the global periodontal therapeutics market?
• What will be the Y-o-Y growth of the global periodontal therapeutics market between 2019 and 2027?
• What is the influence of pipeline Systemic Antibiotics on the global periodontal therapeutics market?
• Will North America continue to be the most profitable market for providers of periodontal therapeutics treatment products?
• Which factors will hamper the growth of the global periodontal therapeutics market during the forecast period?
• Which are the leading companies in the global periodontal therapeutics market?

Global Periodontal Therapeutics Market – Segmentation

Product

• Systemic Antibiotics
• Doxycycline
• Minocycline
• Metronidazole
• Others
• Local Antibiotics
• Arestin
• Periochip
• Atridox
• Others

Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Drug Stores
• E-Commerce

Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Periodontal Therapeutics Market

4. Market Overview

    4.1. Introduction

        4.1.1. Product Definition

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Periodontal Therapeutics Market Analysis and Forecast, 2017–2027

        4.4.1. Market Revenue Projections (US$ Mn)

    4.5. Porter’s Five Force Analysis

5. Market Outlook

    5.1. Pricing Analysis

    5.2. Pipeline Analysis

    5.3. Re-imbursement Scenario

6. Global Periodontal Therapeutics Market Analysis and Forecast, by Product 

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value Forecast, by Product, 2017–2027

        6.3.1. Systemic Antibiotics

            6.3.1.1. Doxycycline

            6.3.1.2. Minocycline

            6.3.1.3. Metronidazole

            6.3.1.4. Others

        6.3.2. Local Antibiotics

            6.3.2.1. Arestin

            6.3.2.2. Periochip

            6.3.2.3. Atridox

            6.3.2.4. Others

    6.4. Market Attractiveness, by Product 

7. Global Periodontal Therapeutics Market Analysis and Forecast, by Distribution Channel 

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value Forecast, by Distribution Channel, 2017–2027

        7.3.1. Hospitals Pharmacies

        7.3.2.  Retail Pharmacies

        7.3.3. Drug Stores

        7.3.4. E-Commerce

    7.4. Market Attractiveness Analysis, by Distribution Channel 

8. Global Periodontal Therapeutics Market Analysis and Forecast, by Region

    8.1. Key Findings

    8.2. Market Value Forecast, by Region

        8.2.1. North America 

        8.2.2. Europe 

        8.2.3. Asia Pacific 

        8.2.4. Latin America 

        8.2.5. Middle East & Africa 

    8.3. Market Attractiveness Analysis, by Region

9. North America Periodontal Therapeutics Market Analysis and Forecast

    9.1. Introduction

        9.1.1. Key Findings

    9.2. Market Value Forecast By Product, 2017–2027

        9.2.1. Systemic Antibiotics

            9.2.1.1. Doxycycline

            9.2.1.2. Minocycline

            9.2.1.3. Metronidazole

            9.2.1.4. Metronidazole

            9.2.1.5. Others

        9.2.2. Local Antibiotics

            9.2.2.1. Arestin

            9.2.2.2. Periochip

            9.2.2.3. Atridox

            9.2.2.4. Others

    9.3. Market Value Forecast, by Distribution Channel, 2017–2027

        9.3.1. Hospitals Pharmacies

        9.3.2.  Retail Pharmacies

        9.3.3. Drug Stores

        9.3.4. E-Commerce

    9.4. Market Value Forecast, by Country, 2017–2027

        9.4.1. U.S.

        9.4.2. Canada

    9.5. Market Attractiveness Analysis 

        9.5.1. By Product 

        9.5.2. By Distribution Channel 

        9.5.3. By Country

10. Europe Periodontal Therapeutics Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Market Value Forecast, by Product, 2017–2027

        10.2.1. Systemic Antibiotics

            10.2.1.1. Doxycycline

            10.2.1.2. Minocycline

            10.2.1.3. Metronidazole

            10.2.1.4. Others

        10.2.2. Local Antibiotics

            10.2.2.1. Arestin

            10.2.2.2. Periochip

            10.2.2.3. Atridox

            10.2.2.4. Others

    10.3. Market Value Forecast, by Distribution Channel, 2017–2027

        10.3.1. Hospitals Pharmacies

        10.3.2.  Retail Pharmacies

        10.3.3. Drug Stores

        10.3.4. E-Commerce

    10.4. Market Value Forecast, by Country/Sub-region, 2017–2027

        10.4.1. Germany

        10.4.2. U.K.

        10.4.3. France

        10.4.4. Spain

        10.4.5. Italy

        10.4.6. Rest of Europe

    10.5. Market Attractiveness Analysis 

        10.5.1. By Product 

        10.5.2. By Distribution Channel 

        10.5.3. By Country/Sub-region

11. Asia Pacific Periodontal Therapeutics Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value Forecast, by Product, 2017–2027

        11.2.1. Systemic Antibiotics

            11.2.1.1. Doxycycline

            11.2.1.2. Minocycline

            11.2.1.3. Metronidazole

            11.2.1.4. Others

        11.2.2. Local Antibiotics

            11.2.2.1. Arestin

            11.2.2.2. Periochip

            11.2.2.3. Atridox

            11.2.2.4. Others

    11.3. Market Value Forecast, by Distribution Channel, 2017–2027

        11.3.1. Hospitals Pharmacies

        11.3.2.  Retail Pharmacies

        11.3.3. Drug Stores

        11.3.4. E-Commerce

    11.4. Market Value Forecast, by Country/Sub-region, 2017–2027

        11.4.1. China

        11.4.2. Japan

        11.4.3. India

        11.4.4. Australia & New Zealand

        11.4.5. Rest of Asia Pacific

    11.5. Market Attractiveness Analysis 

        11.5.1. By Product 

        11.5.2. By Distribution Channel 

        11.5.3. By Country/Sub-region

12. Latin America Periodontal Therapeutics Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value Forecast, by Product, 2017–2027

        12.2.1. Systemic Antibiotics

            12.2.1.1. Doxycycline

            12.2.1.2. Minocycline

            12.2.1.3. Metronidazole

            12.2.1.4. Others

        12.2.2. Local Antibiotics

            12.2.2.1. Arestin

            12.2.2.2. Periochip

            12.2.2.3. Atridox

            12.2.2.4. Others

    12.3. Market Value Forecast, by Distribution Channel, 2017–2027

        12.3.1. Hospitals Pharmacies

        12.3.2.  Retail Pharmacies

        12.3.3. Drug Stores

        12.3.4. E-Commerce

    12.4. Market Value Forecast, by Country/Sub-region, 2017–2027

        12.4.1. Brazil

        12.4.2. Mexico

        12.4.3. Rest of Latin America

    12.5. Market Attractiveness Analysis 

        12.5.1. By Product 

        12.5.2. By Distribution Channel 

        12.5.3. By Country/Sub-region

13. Middle East & Africa Periodontal Therapeutics Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value Forecast, by Product, 2017–2027

        13.2.1. Systemic Antibiotics

            13.2.1.1. Doxycycline

            13.2.1.2. Minocycline

            13.2.1.3. Metronidazole

            13.2.1.4. Others

        13.2.2. Local Antibiotics

            13.2.2.1. Arestin

            13.2.2.2. Periochip

            13.2.2.3. Atridox

            13.2.2.4. Others

    13.3. Market Value Forecast, by Distribution Channel, 2017–2027

        13.3.1. Hospitals Pharmacies

        13.3.2.  Retail Pharmacies

        13.3.3. Drug Stores

        13.3.4. E-Commerce

    13.4. Market Value Forecast, by Country/Sub-region, 2017–2027

        13.4.1. GCC Countries

        13.4.2. South Africa

        13.4.3. Rest of Middle East & Africa

    13.5. Market Attractiveness Analysis 

        13.5.1. By Product 

        13.5.2. By Distribution Channel 

        13.5.3. By Country/Sub-region

14. Competition Landscape

    14.1. Market Player - Competition Matrix (By Tier and Size of companies)

    14.2. Market Share/Position Analysis, by Company, 2018

    14.3. Company Profiles

        14.3.1. 3M Company

            14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.1.2. Growth Strategies

            14.3.1.3. SWOT Analysis

        14.3.2. Den-Mat Holdings, LLC 

            14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.2.2. Growth Strategies

            14.3.2.3. SWOT Analysis

        14.3.3. Dexcel Pharma

            14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.3.2. Growth Strategies

            14.3.3.3. SWOT Analysis

        14.3.4. Kaken Pharmaceutical Co., Ltd.

            14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.4.2. Growth Strategies

            14.3.4.3. SWOT Analysis

        14.3.5. Oral Science 

            14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.5.2. Growth Strategies

            14.3.5.3. SWOT Analysis

        14.3.6. Valeant Pharmaceuticals International, Inc. 

            14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.6.2. Growth Strategies

            14.3.6.3. SWOT Analysis